Introduction {#S0001}
============

When headache is frequent, chronic and long-lasting, we possibly encounter a complex although non critical issue.^[@CIT0001]^ Almost all recurrent episodic headaches can potentially be turned into chronic type.^[@CIT0002]^ Chronic daily headache (CDH), described as a primary headache occurring at least 15 days per month for more than 3 months, is perceived as a worldwide problem reported by roughly 4% of the population.^[@CIT0003]^ Advances in biomedical technologies such as functional neuro-imaging may offer hope for a more in-depth studies aiming to explain CDH etiology as well as its relation with psychosocial and environmental factors.^[@CIT0003],\ [@CIT0004]^ CDH is not a diagnosis but an entity comprising various disorders resembling primary and secondary headaches. As all organic etiologies of chronic headache must be considered, the diagnosis array comprising tension type headache, migraine, cluster headache, hemicrania continua, medication overuse headache (i.e. following acute phase medications use more than 10 days per month for three months) should be sought.^[@CIT0005],\ [@CIT0006]^

CDH pathogenesis is distinct from episodic headaches that makes further investigations necessary. One of the diagnostic criteria for CDH is normal laboratory assessments and conventional imaging such as computed tomography (CT) scan and magnetic resonance imaging (MRI).^[@CIT0007]^ More recent imaging techniques using the tissue paramagnetic properties can reveal magnetic, biochemical and physiologic tissue characteristics even before anatomical changes. This can help understanding the pathophysiology of diseases which have remained unexplained so far. Using diffusion, perfusion and BOLD (blood oxygen level dependent) MRI, we can detect the regional functions of the brain.^[@CIT0001],\ [@CIT0006],\ [@CIT0008]--[@CIT0010]^ As a distinct brain regional function increases, blood flow to that region peaks, thus deoxy hemoglobin / oxyhemoglobin ratio declines. This effect causes signal changes in functional MRI (fMRI). Some fMRI investigations on different headache types including CDH have indicated enhanced signal intensity in specific brain regions.^[@CIT0001],\ [@CIT0006],\ [@CIT0011]^

We hypothesized that there should be some specific regions within or outside the pain matrix of the brain^[@CIT0012]^ governing this chronic type headache. These areas may possibly subject to dysfunction in severe headache episodes.^[@CIT0011],\ [@CIT0012]^ Given this, we comprehensively assessed four CDH patients upon their self-rated most severe headache episodes. By means of clinical (history, physical examination and neuropsychological assessments) and paraclinical \[electroencephalogram (EEG), transcranial Doppler (TCD) and fMRI\] evaluations, we aimed to arrive at possible culprits for their severe, persisting and intractable headaches. Since the headache pattern varies from patient to patient and cross-cases comparisons does not seem to be possible, we compared each patient\'s data with his/her own off-headache condition. The purpose of this investigational case series was to use fMRI and other findings to possibly define the partial pathophysiological mechanism(s) involved in CDH.

Materials and Methods {#S0002}
=====================

This investigational case series recruited four patients (three females and one male; 47.7 ± 10.5 years old) who had been suffering from CDH for more than 3 years. These patients, who fulfilled the international classification of headache disorders' criteria for CDH^[@CIT0003]^, were interviewed and got an informed consent signed before entering the investigation. A focused history was taken and systemic and neurological examinations were performed on each patient. Neuropsychological assessments were done using the validated Farsi versions of Addenbrooke\'s neurocognitive battery (ACE),^[@CIT0013]^ Beck\'s depression^[@CIT0014]^ and anxiety^[@CIT0015]^ inventories (BDI-II, BAI). Furthermore, sleep quality indices and excessive daytime sleepiness assessment were done using the validated Farsi version of the Pittsburgh Sleep Quality Index (PSQI)^[@CIT0016]^ and the Epworth Sleepiness Scale (ESS)^[@CIT0017]^, respectively.

Experiment 1: Baseline neurological evaluation {#S20003}
----------------------------------------------

Initially, all patients underwent conventional brain MR Imaging to rule out any possible structural brain lesions. Routine lab data were also collected. Patients were trained to report the severity of their headache episodes using the visual analogue scale score (VAS).^[@CIT0018]^ Upon self-rated VAS score of 0-3/10 which represented no or minimal headache, patients underwent EEG, TCD and fMRI studies. The second series of the same assessments were done when patients reported the worst experienced headache over the past 30 days; self-scored 8-10/10 on VAS.

Experiment 2: Neuropsychological assessments {#S20004}
--------------------------------------------

All neuropsychological assessment questionnaires were in local language, having been validated for internal consistency and test--retest reliability was confirmed in published literature.^[@CIT0013]--[@CIT0017]^ The scoring data were presented and interpreted according to the questionnaires' manuals.

Experiment 3: TCD evaluation {#S20005}
----------------------------

We did TCD examination in all cases during their maximal and minimal (or no) headache episodes. Transcranial Doppler insonation of brain vessels were done, using a 2 MHz probe through temporal, transorbital and transforaminal windows to assess the blood flow velocity in anterior, middle and posterior cerebral, ophthalmic and vertebrobasilar arteries. The common, internal and external carotid arteries were insonated using a 4 MHz probe. The TCD findings for the four cases are summarized in [Table 1](#T0001){ref-type="table"}.

###### 

Transcranial Doppler Findings

                              MCA   ACA   PCA   Ophth   Siph   ICA   VA   Bas
  ------------------- ------- ----- ----- ----- ------- ------ ----- ---- -----
  Case 1 (P. K.)                                                          
   Without headache   Right   43    44    26    24      41     49    33   
                      Left    44    38    24    23      50     49    30   30
   With headache      Right   47    43    29    27      43     49    33   
                      Left    64    46    26    25      55     53    32   35
  Case 2 (S. S.)                                                          
   Without headache   Right   73    58    41    21      55     54    38   
                      Left    70    48    38    21      58     50    52   62
   With headache      Right   76    54    45    22      56     63    49   
                      Left    63    71    46    17      56     56    60   65
  Case 3 (A. J.)                                                          
   Without headache   Right   64    58    40    21      62     49    37   
                      Left    65    61    31    19      64     47    38   56
   With headache      Right   54    49    23    23      60     41    33   
                      Left    57    50    27    20      63     35    35   48
  Case 4 (M. K.)                                                          
   Without headache   Right   60    44    31    23      43     33    45   
                      Left    66    55    34    21      43     43    32   33
   With headache      Right   42    59    34    23      39     39    36   
                      Left    48    46    31    25      41     48    37   34

The mean arterial flow velocities in studied vessels are summarized. All values are in cm/s. MCA: Middle Cerebral Artery, ACA: Anterior Cerebral Artery, PCA: Posterior Cerebral Artery, Ophth: Ophthalmic artery, Siph: Carotid Siphon, ICA: Internal carotid Artery, VA: Vertebral Artery, Bas: Basilar Artery.

Case 1 study revealed a diminished mean blood flow velocity bilaterally in MCA and PCA during off-headache evaluation. It however, showed an increase in mean blood flow velocity in left MCA upon maximal intensity headache by 50%. Other cases' TCD study showed no significant differences in values obtained during off-headache and maximal headache evaluations.

Experiment 4: Electrophysiology assessments {#S20006}
-------------------------------------------

In this experiment, EEG findings in and outside the headache bouts were compared in terms of possible presence of abnormal features.

Experiment 5: Functional MRI to assess brain anatomical points possibly engaged in pain related neural activations {#S20007}
------------------------------------------------------------------------------------------------------------------

We used fMRI recorded BOLD response during patients' maximal headache and off or minimal headache episodes based on the self-scored VAS. For the maximal headache scans, patients were scanned within 4 hours since they reported the maximal intensity headache. Imaging was performed using a 1.5 T Siemens scanner with a quadrature head coil. A gradient echo planar imaging (EPI) sequence with time echo to time repetition ration of 30/2500 was conducted. By this, 74 volumes were captured upon each scan. Functional scans comprised 33 slices (3.5 mm thick with a 3.5mm in-plane resolution i.e. 64 x 64) in oblique orientation, matching the brain stem axis. The obtained functional data in either maximal or minimal (or no) headache states were then analyzed using scripts in FMRIB\'s Software Library (FSL, <http://www.fmrib.ox.ac.uk/fsl>). None of the subjects demonstrated signs of gross movement (\>1 voxel) during the functional scans. Captured volumes were spatially smoothed with a 5 mm full-width at half maximum filter.^[@CIT0019],\ [@CIT0020]^

The analyzed data were used for a group-level activation map, employing the mixed-level model. The difference in brain activation level between maximal and minimal (or no) headache episode signals was done through a voxel-wise paired t-test. Significant voxels were identified within the regions of interest showing BOLD activity. The fMRI shown activated brain regions during maximal or minimal (or no) intensity headaches were then co-registered with the anatomical images using FMRIB\'s Linear Image Registration tool to identify which brain anatomical points has possibly engaged in pain related neural activations.^[@CIT0020]^.

Cases and the corresponding core findings {#S0008}
=========================================

Case 1 {#S20009}
------

P. K., a 52-year-old married female, mother of two children, with MA educational level had suffered from chronic headache since 20 years ago. For many years, the headaches were mild to moderate with long intervals. Following an emotional stressor, she started to experience regular and more intense headaches since 8 years ago and turned to a case of CDH since 3 years prior to the current presentation. She mainly complained of nocturnal headaches aggravated by intense emotions. Headaches were most often unilateral on the left side. Upon attacks, she became nauseated and sensitive to photic or acoustic stimuli. The headache was refractory to various analgesics. The patient\'s past medical history was not significant. There was a positive family history of intense headache in her mother and sister. She had no medication history except analgesics. Likewise, she had received no prophylactic regimen for the headaches.

Neurological examinations and conventional MRI were normal. On psychological assessments, she had normal cognitive performance status (MMSE and ACE); however, BAI, BDI-II and PSQI scales showed that she had moderate anxiety and depression as well as poor global sleep quality. The psychological assessment results of all four cases are outlined in [Table 2](#T0002){ref-type="table"}.

###### 

The psychological assessments of four cases

  Psychological Testing                                    Case 1 (P.K.)                            Case 2 (S.S.)                         Case 3 (A.J.)                          Case 4 (M.K.)
  -------------------------------------------------------- ---------------------------------------- ------------------------------------- -------------------------------------- -------------------------------------
  Mini-mental state examination, MMSE (Max: 30)            28                                       29                                    24                                     29
  Addenbrooke\'s Cognitive examination, ACE-P (Max: 100)   89                                       95                                    65                                     86
  Subscales                                                                                                                                                                      
  Attention and orientation (Max: 18)                      17                                       18                                    11                                     17
  Memory (Max: 26)                                         22                                       26                                    19                                     20
  Verbal fluency (Max: 14)                                 9                                        11                                    7                                      7
  Language (Max: 26)                                       22                                       26                                    17                                     20
  Visuo-spatial ability (Max: 16)                          16                                       14                                    8                                      15
  Beck\'s anxiety inventory score ( BAI)                   21[\*](#TF0003){ref-type="table-fn"}     2[□](#TF0001){ref-type="table-fn"}    6[□](#TF0001){ref-type="table-fn"}     6[□](#TF0001){ref-type="table-fn"}
  Beck\'s depression inventory ( BDI-II)                   31[\*\*](#TF0005){ref-type="table-fn"}   4[β](#TF0002){ref-type="table-fn"}    14[µ](#TF0009){ref-type="table-fn"}    9[β](#TF0002){ref-type="table-fn"}
  Pittsburg Sleep Quality Index ( PSQI)                    14[§](#TF0005){ref-type="table-fn"}      4[¥](#TF0007){ref-type="table-fn"}    11[µµ](#TF0010){ref-type="table-fn"}   15[§](#TF0005){ref-type="table-fn"}
  Epworth sleepiness Scale (ESS)                           14[¶](#TF0006){ref-type="table-fn"}      5[¶¶](#TF0008){ref-type="table-fn"}   9[¶](#TF0006){ref-type="table-fn"}     15[¶](#TF0006){ref-type="table-fn"}

Max: Maximum score of each scale

Minimal anxiety

Minimal depression

Moderate anxiety, µ: Mild depression

Severe depression

Poor sleep quality

Excessive sleepiness

Proper sleep quality

No excessive sleepiness

Mild depression

Moderate sleep quality

Off-headache EEG demonstrated scattered sharp wave activity. The repeated EEG evaluation during the maximal headache episode, turned out to reveal generalized paroxysmal epileptiform activity. [Figure 1](#F0001){ref-type="fig"} illustrates her EEG patterns during off-headache and maximal headache episodes.

![Electroencephalogram (EEG) study epochs belonging to case 1\
Although with no history of seizure and being awake and conscious during the EEG recording, she demonstrated scattered sharp waves during off-headache EEG assessment (A) as well as paroxysmal generalized epileptiform activity during maximal headache EEG study (B, C and D).](IJNL-11-127-g001){#F0001}

TCD findings in headache-free evaluation indicated a diminished mean blood flow velocity in bilateral middle and posterior cerebral arteries (MCA and PCA). However, it showed an increase in mean blood flow velocity in left MCA upon maximal intensity headache (the headache site, by 50%). Routine lab data was within normal limits. After all, the clinical impression was chronic migraine headache.

Case 2 {#S20010}
------

S. S., a 32-year-old married female, no children, with MSc educational level who had the complaint of 'on and off' mild to moderate headache for many years. Her more intense and frequent headache attacks started 5 years ago and had been a case of CDH (over 15 days per month headache) over the past 3 years. Her headache bouts were almost always very intense (rated 8-10/10 in VAS) especially when she was physically tired and was partially alleviated by sleep. She reported a unilateral (mainly right hemispheric) throbbing headache with no concurrent nausea, vomiting, photophobia and phonophobia during the episodes. Presence of headache did not follow a diurnal pattern. The patient neither had a significant past medical nor a family history of headache. The medication and substance use history was negative except for simple analgesics in routine basis. General and neurological physical examinations, laboratory workups and brain MRI were within normal limits. Her psychological assessments demonstrated normal cognitive functioning (MMSE and ACE); however, a minimal anxiety and depression was detected based on BAI and BDI-II scales, respectively. PSQI showed an appropriate sleep quality ([Table 2](#T0002){ref-type="table"}).

EEG and TCD studies upon maximal and headache-free episodes were unremarkable, showing no quantitative and qualitative differences in both states as compared to each other. The clinical impression for this case was again, chronic migraine headache.

Case 3 {#S20011}
------

A. J. was a 53-year-old female, widow, with no children, and illiterate. She revealed the history of quite often headaches responsive to analgesics since 5 years ago. After the loss of her husband (three years ago) she started to have chronic headache which affected her for more than 15 days per month. The headache was mainly bilateral and retro-orbital and if unilateral, was in right side involving occipital and upper cervical regions. The pain had a constrictive nature however not accompanied by nausea, vomiting, photophobia and phonophobia. The headache was aggravated during emotional stresses and alleviated by rest. In the past medical history, she had infertility. She used to take non-steroidal anti-inflammatory drugs (NSAIDs) for her chronic headache, which was not any more effective Moreover, the patient had not been administered prophylactic regimens for the headaches. Family history was not significant. Apart from the body mass index of 28, general physical examination was normal. Neurological examination, lab data and brain MRI were also within normal limits. Psychological evaluations (despite the illiteracy issue) showed a normal cognitive profile (MMSE and ACE). BAI and BDI-II scales showed a minimal anxiety and depression. Her sleep quality was impaired based on PSQI ([Table 2](#T0002){ref-type="table"}). EEG and TCD evaluations in maximal and headache-free episodes' were normal. Lab data were inconclusive. The clinical impression we had, was the chronic tension type headache.

Case 4 {#S20012}
------

M. K. was a 54-year-old male, married, father of two children and with educational level of PhD. He reported mild transient headache since young adulthood, becoming a known case of migraine when he was 26 years old. He used to take ergotamine--C upon headache during those years. Due to severity and frequency of episodes, he was given prophylactic regimens since the age of 40; however, became refractory in a matter of few years. He was labeled as CDH since 5 years ago. The headache had been intrusive in over 20 days per month lasting 15 hours per day in average. Headaches are mostly bilateral, causing photophobia and phonophobia and accompanied by nausea and vomiting in severe instances. The headache timing did not follow a distinct pattern; however, was more intense at nights. Pain was partly alleviated by sleep. His past medical history was negative. He revealed a family history of migraine in her mother. Over the past few years, he experienced various medications including prophylactic tetracyclic antidepressant, benzodiazepines, antiepileptic, beta blockers and lithium carbonate to all which he failed response. He had recently been taking sumatriptan and ergotamine as abortive medication upon headache episodes, with a very modest response. His general and neurologic examinations as well as the conventional brain MRI with and without contrast were normal. His psychological assessments indicated a normal neuro-cognitive state (MMSE and ACE); however, with a minimal anxiety and depression based on BAI and BDI-II. His sleep quality was evaluated poor, as per PSQI ([Table 2](#T0002){ref-type="table"}).

He had no significant findings during maximal and minimal headache EEG and TCD evaluations. After all assessments, our impression was medication overuse headache (MOH). His acute phase medications were discontinued and interestingly, after many years, his headache turned into less intense with an episodic pattern, once or twice a week.

The group-level fMRI activation map {#S20013}
-----------------------------------

As described in experiment 4, fMRI data in group-level was acquired through BOLD signal acquisition and FSL based analysis. Head motion was corrected, if any. Detailed data analysis per protocol, indicated a difference in brain activation level between maximal and minimal (or no) headache episode signals. There were areas not active in headache-free state, however active during maximal headache. This was documented by a voxel-wise paired t-test. We then co-registered the fMRI with the anatomical images through FMRIB\'s Linear Image Registration tool. In our group-level analysis, bilateral occipital and to the lesser extent frontal pole regions were active during headache but not active in headache free (or minimal headache) states. The above findings are shown in [Figure 2](#F0002){ref-type="fig"}.

![fMRI group level activation map for BOLD response during off or minimally presented headache based on the self scored VAS using (A) and during maximal headache episodes (B, C and D). Functional data were analyzed using scripts in FMRIB\'s Software Library (FSL). The analyzed data were used for a group-level activation map, through the mixed-level model. The voxel wise paired t-test was employed to distinguish possible differences in activation during off-headache and maximal headache state fMRI assessment. During headache bouts, group-level activation map fMRI, revealed a markely increased BOLD signal in bilateral occipital regions (B, C) and also modest fronto-polar BOLD signal increase(D). These changes were not seen in off-headache conditions (A).](IJNL-11-127-g002){#F0002}

Discussion {#S0014}
==========

Headache is one of the most important health problems in our community.^[@CIT0021],\ [@CIT0022]^ Among the different types of prevalent headaches, CDH or chronic daily headache as a persistent headache not responding to treatments, brings along concern and discomfort both for patients and physicians dealing with the problem.^[@CIT0004],\ [@CIT0023]^ Most of the studies employing functional neuro-imaging have considered migraine headaches^[@CIT0001],\ [@CIT0004],\ [@CIT0005],\ [@CIT0009],\ [@CIT0010],\ [@CIT0023]^ and CDH as specific types of headache that have minimally been investigated in-depth.

To the best of knowledge, studies on patients with CDH having simultaneously performed an array of diagnostic measures such as EEG, TCD, and fMRI are scant. An EEG, TCD and SPECT investigation done in one patient with migraine, reported a decrease in TCD flow velocity in aura phase and increased flow velocity upon bouts of headaches.^[@CIT0024]^ In this study, when patient was experiencing aura, EEG revealed slow waves in bilateral occipital regions, and SPECT demonstrated right parieto-occipital hypo perfusion. All these phenomena reversed upon relief of the headache.^[@CIT0024],\ [@CIT0025]^

Other studies which used EEG at rest and during the headache attacks indicated that, upon headache there were evident changes in frequency and amplitude of alpha bands as well as presence of diffused theta and delta waves in the brain; however, no report has revealed presence of epileptiform activity upon headache attacks.^[@CIT0026],\ [@CIT0027]^ This is in contrast to our findings. Upon EEG evaluation, our 'case 1' showed generalized paroxysmal epileptiform activity during maximal headache. This patient had no history of epilepsy and despite epileptiform activity during maximal headache EEG evaluation, remained fully alert and oriented to her surroundings. She also did not show such EEG presentations when the assessment was repeated off-headache.

Vernieri et al. studied 12 migraine headache patients using TCD. Patients with unilateral headache, showed cerebrovascular reactivity to the opposite side upon headache as compared to off-headache condition.^[@CIT0028]^ In another TCD study on children with migraine headache, 23 out of 62 cases showed increased mean arterial flow velocity.^[@CIT0029]^ Likewise, we observed an increase in flow velocity of left MCA (the point where the patient suffered maximal headache intensity although the headache was generalized). The flow velocity increased from 44 cm/s to 64 cm/s which were a significant rise upon headache. We however, did not observe any significant changes in cerebral arterial mean flow velocity in our other cases upon headache as compared to off-headache conditions.

Studies assessing patients with various types of headache with functional neuro-imaging (fMRI), demonstrated controversial results. According to Chiapparini and his associates,^[@CIT0009]^ cases with migraine and medication overuse headache, revealed a decreased activity and hypo metabolism in cortical areas affected during pain sensation, including the periaqueductal gray (PAG) and the substantia nigra (SN). These fMRI changes reversed when the responsible medications were stopped. The fMRI included investigation by Grazzi and colleagues^[@CIT0030]^ indicated a diminished activity in right supramarginal and parietal cortices in patients with medication overuse headache. These changes returned to normal 6 month after discontinuation of respective medications. Arne May et al.^[@CIT0006],\ [@CIT0011]^ reported that, during migraine attacks there are some hyper activated regions in the brainstem; while during bouts of trigeminal neuralgia some hypothalamic sub-regions get activated. Moreover, they reported that during migraine headache, cerebral blood flow gets diminished in posterior parts of the brain; however, BOLD signals enhance in occipital regions.^[@CIT0011]^ These findings are partly in line with what we observed during our fMRI assessment. Cao et al. similarly documented that during aura phase of migraine (induced by photic stimulation), the neural activity in occipital lobes declines whereas upon headache phase, occipital lobes become hyper-oxygenated.^[@CIT0010]^ In Aurora et al. study during which they thoroughly investigated a CDH patient possibly induced with ergotamine overuse, it was found that upon maximal episodes of these headaches red nucleus and substantia nigra were hyper activated while these finding disappeared when the CDH turned into episodic migraine following discontinuation of the culprit drugs.^[@CIT0031]^

We performed an fMRI assessment on 4 patients fulfilling the criteria for CDH. Functional MRIs were taken upon patients' self-rated (VAS) maximal intensity headache episodes and off-headache conditions. Each patient had at least 2 functional images at given conditions. During headache bouts and in group-level activation map fMRI, we observed an increased BOLD signal in bilateral occipital regions. These changes however were not seen in off-headache conditions. Since occipital region is literally outside the classical pain pathway,^[@CIT0012]^ its activation turned to be of special note to us only during the maximal headache.

Since all our patients were reporting a generalized headache while under fMRI scanner and none of them had even a minimal complaint of a localized occipital headache, activation of occipital area might at least partly be attributed to hyper-excitability of this region to the peripheral visual stimuli during headache. This question per se, can be a topic for a separate in-depth investigation.

Conclusion {#S0015}
==========

Despite the current investigation\'s findings and similar reports, the etiopathophysiological features of the refractory headaches such as CDH have remained unclear or just partly understood. As far as we know, this has been the first of a kind fMRI investigation with regard to headache, carried out in Iran. Our core findings, such as 1) presence of epileptiform activity, 2) increased mean cerebral arterial flow velocity, and 3) enhanced occipital lobes' BOLD signals upon headache bouts in CDH, suggest the necessity to conduct more comprehensive and larger studies in this field. These efforts are expected to provide insights regarding the pathophysiology of such debilitating headaches, offering hopes for more efficient treatments in the future.
